Cannabis Law Report

MAY 1, 2023

million to support the development of its MDMA-assisted therapy program in a tranche led by Sixty Two Capital and Taylor Collison. Biotech Emyria (ASX: EMD) has raised $2.5

Therapy 52

Therapy Programs 52

Cannabis Law Report

JUNE 16, 2021

This relationship enables us to initiate our clinical research program and marks an important step for Wake in Canada. We are excited to explore the potential of emergent psychedelic therapies. This news release contains forward-looking statements within the meaning of applicable securities laws. ABOUT SANTÉ CANNABIS.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

Canna Law Blog

NOVEMBER 10, 2020

I was talking to another lawyer about last week’s vote by Oregonians to legalize psilocybin therapy here in the state. Public Law 115-176 (“Right to Try”) is a federal law enacted in 2018 that creates a uniform system for terminal patients seeking access to investigational treatments. Let’s see how it all goes.

Therapy 78

Therapy Clinical Trials Decriminalization Patients 78

Cannabis Law Report

OCTOBER 14, 2021

International Summit on Psychedelic Therapies for Mental Illness. Why do we need psychedelic-assisted therapies? A range of videos and programs for our delegates viewing. Living until you die – the promise of psilocybin-assisted therapy with terminally ill patients. This program is subject to change. Session 1.

Therapy 105

Therapy Medicine Treatment Programs 105

The Cannigma

JUNE 1, 2021

Possessing cannabis is illegal in France, although in 2020, the country changed the law so that the punishment is now a €200 fine. Possessing cannabis is illegal in France, although in 2020, the country changed the law so that the punishment is now a €200 fine. France’s (experimental) medical cannabis program. Shutterstock.

Law 113

Law Epilepsy Programs Patients 113

Cannabis Law Report

MARCH 27, 2023

. (“ATMA”), Canada’s leading psychedelic-assisted therapy training provider, begins its first psychedelic training program highly focused on psilocybin and MDMA, designed for physicians, psychiatrists and prescribers starting April 14, 2023.

Programs 52

Programs Therapy 52

Cannabis Law Report

OCTOBER 20, 2021

International Summit on Psychedelic Therapies for Mental Illness 17-20 November 2021. The event will also feature a two-day pre-Summit Introductory Workshop Program (17-18 November) led by Nigel Denning, Dr Tra-ill Dowie with world-leading therapist trainer Dr Bill Richards (USA) from Johns Hopkins University.

Therapy 52

Therapy Medicine Topical Events 52

Cannabis Law Report

MAY 19, 2022

5 restored its “Special Access Program” — abolished under former prime minister Stephen Harper in 2013 — allowing health-care experts to request access to restricted drugs that have not yet been authorized for sale in the country. “The therapy part has a capital T in this whole process,” Hartle said.

Therapy 52

Therapy Patients Treatment Clinical Trials 52

NORML

MAY 19, 2020

House lawmakers have overwhelmingly approved two bills to amend the state’s medical marijuana program in a manner that significantly expands patients’ access to cannabis products. The state’s medical cannabis program became operational last August.

Access 256

Access Therapy Patients Conditions 256

Cannabis Law Report

FEBRUARY 24, 2022

Canada recently amended its Controlled Drugs and Substances Act (CDSA) to allow for psilocybin and MDMA therapy in limited circumstances. Subsection 56(1) of the CDSA will exempt medical providers from enforcement of the CDSA when providing psilocybin and MDMA treatment to patients suffering serious or terminal health conditions. Conclusion.

Therapy 52

Therapy Access Clinical Trials Treatment 52

Canna Law Blog

NOVEMBER 1, 2021

The Physician Self-Referral Law, commonly referred to as the Stark law (42 U.S.C. 1395nn), is one of several federal fraud and abuse laws. While the two laws may seem similar at first, they have very different rules and penalties. The Stark law has civil penalties, while the AKS has civil and criminal penalties.

Law 87

Law Therapy Treatment Programs 87

The Cannigma

NOVEMBER 11, 2022

Hungary’s laws don’t differentiate between cannabis and harder drugs. More than half of the country’s drug law offenses in 2017 were related to cannabis, and according to Hungarian law, both drug use and possession are punishable by up to two years in prison. The post Cannabis laws in Hungary appeared first on The Cannigma.

Law 59

Law Consumption Programs Cultivation 59

Veriheal

JULY 2, 2020

Louisiana has had a medical cannabis program for many years. However, for patients to qualify for access to medical cannabis, they must have received a diagnosis of at least one of the 14 qualifying conditions that were initially approved under the initial law. The Bill as Passed. Now that the bill has been signed, as of August 1 st.,

Banking 52

Banking Programs Therapy Conditions 52

Cannabis Law Report

APRIL 2, 2022

Founded in 2019, Roots to Thrive is Canada’s first and only multidisciplinary, non-profit healthcare practice to legally offer evidence-informed, multi-week group therapy programs that include psilocybin-assisted and ketamine-assisted group therapy sessions.

Therapy 52

Therapy Research and Development Programs Legalization 52

Cannabis Law Report

JULY 13, 2022

Optimi will supply Bloom with sufficient biomass of natural psilocybin to begin conducting its previously announced clinical trial in partnership with the IMPACT Clinical Trial Accelerator Program housed within Alberta’s Life Sciences Innovation Hub at the University of Calgary.

Therapy 52

Therapy Clinical Trials Microdosing Research and Development 52

Cannabis Law Report

MARCH 9, 2023

OPB reports An executive for Synthesis Institute informed students Monday that the business was bankrupt and would end its efforts to deliver therapy under Measure 109. million tractsouth of Ashland in June 2021, the company hailed it as the future of psychedelic-assisted therapy in Oregon. […]

Programs 52

Programs Therapy Business 52

Cannabis Law Report

JUNE 16, 2019

Steve Schain , Senior Attorney at Hoban Law Group. On May 13th New Jersey’s Department of Health (“DOH”) amended it Medicinal Marijuana Program Rules, N.J.A.C. Steve Schain is a Senior Attorney to Hoban Law Group and admitted to practice in Pennsylvania and New Jersey. Steve Schain. 24:6I-1, Et.

Programs 77

Programs Chronic Pain Marijuana Conditions 77

Veriheal

NOVEMBER 11, 2023

Simply put, in the eyes of federal law, cannabis is illegal. The Department of Veterans Affairs (VA) falls under federal government control which means it must obey all federal laws, including every cannabis law. According to Federal law, cannabis use is illegal. However, there can be penalties based on federal laws.

Law 62

Law Chronic Pain Conditions Legislation 62

Veriheal

JULY 6, 2021

Wait, Tennessee has a medical cannabis program? What Tennessee does have are relaxed laws surrounding some high CBD products and low THC products. Let’s recap what the laws are and have been in Tennessee regarding the medical use of cannabis. The Evolution of Tennessee’s Medical Cannabis Program.

Programs 52

Programs Oil Epilepsy THC 52

Cannabis Law Report

JULY 9, 2021

The state of the law on psychedelic substances is in flux. The use of psychedelic substances to treat mental illness and physical disorders is known as “psychedelic therapy.” Psychedelic therapy is not a fringe phenomenon. Some of the most promising substances, and the law applicable to each, are outlined below: Psilocybin.

Law 105

Law Therapy Clinical Trials Research and Development 105

SpeedWeed

JULY 6, 2021

Harvard Law School is planning to open the first US policy center focused on the legalization and regulation of psychedelics like psilocybin, MDMA, and LSD. . This new program is being funded by private investors, including Matt Wullenweg, developer of WordPress, and philanthropist Tim Ferriss. Professor of Law at Harvard Law School.

Policy 52

Policy Law Research and Development Therapy 52

MMJ Recs

JANUARY 20, 2024

With a nuanced approach to medical marijuana laws, the state has embarked on a journey that seeks to balance patient well-being, regulatory oversight, and societal concerns. Let’s take a closer look at medical marijuana laws in Maryland and how they affect those in need of MMJ treatment!

Law 52

Law Marijuana Patients Chronic Pain 52

Cannabis Law Report

MAY 4, 2022

Under both the budget bill and HB 5396 , psychedelic treatment centers would be established in the state where people could receive psilocybin-assisted or MDMA-assisted therapy as part of an expanded access program for investigational new drugs through the federal Food and Drug Administration (FDA).

Treatment 52

Treatment Programs Therapy Access 52

NORML

MAY 27, 2020

Members voted 28 to 6 in favor of an amended version of House Bill 819, which expands the discretion of physicians so that they can recommend cannabis therapy for “any condition” that he or she “considers debilitating to an individual patient and is qualified through his [or her] medical education and training to treat.”

Conditions 276

Conditions Legislation Therapy Patients 276

Cannabis Law Report

MARCH 15, 2021

David Bronner calls out the never ending creep of Compass or as he puts it…… Their monopolistic and shady… Read More.

Therapy 64

Therapy Programs 64

Veriheal

MAY 31, 2022

With a worsening opioid situation and an emerging acceptance of medical cannabis, the Lone Star State has a unique opportunity to develop a successful medical marijuana (MMJ) program for its millions of residents battling chronic pain and numerous other conditions. Vital Changes to Texas’ Medical Cannabis Program. More Telemedicine.

Programs 52

Programs Chronic Pain Treatment Conditions 52

Cannabis Law Report

MAY 17, 2023

Marijuana Moment reports A North Carolina House committee has approved a bill to create a $5 million grant program to support research into the therapeutic potential of psilocybin and MDMA and to create a Breakthrough Therapies Research Advisory Board to oversee the effort. Edward Goodwin (R) and other […]

Therapy 98

Therapy Legislation Programs Marijuana 98

Cannabis Law Report

DECEMBER 5, 2021

Revenue share payments will be based on North America sales of MDMA for use in MDMA-assisted therapy, will terminate after 8 years, and include a reciprocity payment structure that reduces payments once certain financial milestones are met.

Therapy 52

Therapy Access Research and Development Clinical Trials 52

Veriheal

FEBRUARY 3, 2022

To participate in Oklahoma’s medical cannabis program, all that patients need to do is meet with a doctor and receive a medical marijuana recommendation. This gave doctors the freedom to recommend medical cannabis for any symptom, illness, or condition they felt cannabinoid therapies would be appropriate for.

Programs 52

Programs Seed-To-Sale Wellness and Beauty Compliance 52

Cannabis Law Report

MAY 6, 2021

EMDMA-001 has been modelled on a major Phase III clinical trial developed by the Multidisciplinary Association for Psychedelic Studies (MAPS).… … Read More.

Clinical Trials 59

Clinical Trials Therapy Programs Medicine 59

SpeedWeed

JUNE 14, 2021

State officials tasked with overseeing Ohio’s medical marijuana program approved last week the addition of three health conditions that qualify a patient to use cannabis medicinally. The addition of all three, new, medical conditions to the Ohio Medical Marijuana Control Program (OMMCP) is effective immediately. View original article.

Conditions 40

Conditions Programs Therapy Patients 40

MMJ Recs

MARCH 20, 2024

Many dispensaries also offer additional services such as educational resources, patient consultations, and ongoing support programs to address patient concerns and enhance their overall treatment experience. Stay informed about these updates to maximize the benefits of Maryland’s medical cannabis program.

Dispensary 52

Dispensary Programs Access Patients 52

Cannabis Law Report

JUNE 23, 2021

In addition to the pilot program, the parties are working toward an exclusive, definitive supply and distribution agreement, which, if entered into, is expected to position Medicann as the sole supplier and distributor of the RYAH Smart Dry Herb Inhalers in the region. to reach 3.2 billion euros ($3.75 billion) by 2025. 310.299.1717 Office.

Programs 100

Programs Data Events Collective 100

Cannabis Law Report

DECEMBER 2, 2021

Recommendations and rulemaking relating to training and products were placed on an expedited timeline to ensure that facilitators will be trained, and products will be ready for the January 2, 2023, launch of the first state-sponsored psilocybin therapy program in the United States. Conducting Psilocybin Integration (14 Hours).

Law 52

Law Programs Therapy Education 52

Cannabis Law Report

NOVEMBER 4, 2021

The licensing subcommittee adopted an equity subcommittee recommendation requiring all psilocybin license applications to include an equity plan, and the training subcommittee has included equity-centered curriculum in their proposed training program. Licensing Subcommittee. Training Subcommittee Updates. You can contact Brett Mulligan at?

Law 52

Law Therapy Treatment Policy 52

Cannabis Law Report

OCTOBER 12, 2021

Leveraging its deep expertise in nucleic acid-based technologies, the Company has also established safeCircle™, a pooled COVID-19 testing program that is grounded in the Company’s EUA-authorized Linea™ COVID-19 Assay Kit. Key end-markets include textiles, pharmaceuticals and nutraceuticals, and cannabis, among others.

Programs 52

Programs Clinical Trials Research and Development Therapy 52

MMJ Recs

NOVEMBER 17, 2023

Promoting Research and Innovation The medical marijuana industry promotes research and innovation in the field of cannabis-based therapies. Revenue Generation: Maryland’s MMJ program generates revenue for the state, which can be reinvested in public services and healthcare initiatives.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98